11:53 AM EDT, 10/17/2025 (MT Newswires) -- European stock markets closed lower in Friday trading as The Stoxx Europe 600 fell 0.92%, Germany's DAX dropped 1.74%, the FTSE 100 was down 0.86%, France's CAC declined 0.12%, and the Swiss Market Index lost 0.51%.

The annual inflation rate in the euro area was 2.2% in September, up from 2.0% in August, and 1.7% a year earlier, according to Eurostat, the statistical office of the European Union. Meanwhile, the annual inflation rate in the EU was 2.6% in September, up from 2.4% in August and 2.1% a year earlier.

The highest annual rates were in Romania (8.6%), Estonia (5.3%), and Croatia and Slovakia (4.6% each). The lowest annual rates were in Cyprus (0.0%), France (1.1%), and Italy and Greece (1.8% each). Compared with August, the annual inflation rose in 15 member countries, fell in eight, and remained unchanged in four.

And in corporate news, shares of Novo Nordisk fell more than 6% in Friday's trading in Copenhagen after US President Donald Trump reportedly vowed to reduce the price of the company's Ozempic weight-loss drug.

Ozempic's price would be "much lower" once the Trump administration finalizes negotiations with Novo Nordisk, the Financial Times reported, citing Trump's remarks at a Thursday press conference.

The drugmaker didn't immediately respond to MT Newswires' request for comment.

AstraZeneca said Friday that Imfinzi and standard-of-care chemotherapy reduced the risk of death by 22% compared to chemotherapy alone in a phase 3 trial to treat early gastric cancer. The company said that in the final overall survival analysis, an estimated 69% of patients treated with the Imfinzi-based regimen were alive at three years, compared with 62% for standard-of-care chemotherapy.

Shares of AstraZeneca were little changed on the FTSE 100 in London.

BP's Whiting refinery in Indiana has multiple units that are offline, Reuters reported Friday, citing data from Wood Mackenzie. The refinery, which has a capacity of 440,000 barrels per day, was actively flaring early on Friday, a source told Reuters.

BP and Wood Mackenzie did not immediately respond to MT Newswires' request for comment.

Shares of BP were down 0.7% in London.

Sanofi said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion on the marketing authorization application for Rezurock as a third-line treatment for chronic graft-versus-host disease. Sanofi said it will seek a re-examination of the opinion.

Shares of the French pharmaceutical company edged 0.1% higher in Paris.

Ferrari is selling fewer cars in the UK as it seeks to stem declining residual values prompted by the departure of wealthy individuals from the country due to higher tax structures, the Financial Times reported on Friday, quoting CEO Benedetto Vigna.

The report noted that Ferrari has "significantly" reduced the allocation of its cars to the UK, coinciding with the abolition of non-domicile status in April.

Ferrari didn't immediately reply to MT Newswires' request for comment.

Shares of the Italian luxury sports car manufacturer were up 0.7 % in Milan